Korro Bio Shares Fall 11% After Novo Nordisk Ends Collaboration
Korro Bio said Novo Nordisk terminated a research collaboration and license agreement. Korro Bio shares fell 11% to $14.88 midday Thursday, after rising about 86% year to date.
By Josh BeckermanShares of Korro Bio slipped after the biopharmaceutical company said Novo Nordisk terminated a research collaboration and license agreement.Korro Bio's stock fell 11%, to $14.88, midday Thursday, but has risen about 86% year to date.In a securities filing, the company disclosed it…